Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In consultation
In consultation: Guidance and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Consultation end date
Consultation end date
From date
To date
Apply date filters
Type
Type
Guidance (5)
Guidance programme
Guidance programme
Interventional procedures guidance (1)
Technology appraisal guidance (4)
Apply filters
Showing 1 to 5 of 5
Sort by
Date
Title
Apply sorting
Keyword or reference number: cancer
Remove Keyword or reference number: cancer filter
Guidance and quality standards in consultation
Title
Consultation
Type
Consultation end date
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic
cancer
in the liver
Draft scope consultation
Interventional procedures guidance
19 December 2025
Mirvetuximab soravtansine for treating folate receptor alpha-positive platinum-resistant advanced epithelial ovarian, fallopian tube or primary peritoneal
cancer
[ID6442]
Draft guidance
Technology appraisal guidance
17 December 2025
Tarlatamab for treating small-cell lung
cancer
that has progressed after platinum-based chemotherapy ID6617
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
17 December 2025
Toripalimab with chemotherapy for untreated recurrent or metastatic nasopharyngeal
cancer
ID6406
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
11 December 2025
Dostarlimab with platinum-based chemotherapy for advanced or recurrent endometrial
cancer
with microsatellite stability or mismatch repair proficiency [ID6415]
Final draft guidance
Technology appraisal guidance
9 December 2025
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top